Value through Innovation27 July 2016

Clinical Study Results

  • MYCLO ® - Candidiasis, Oral
    Clinical Study Number 1190.1
    Study Indication Candidiasis, Oral
    Product MYCLO ®
    Generic Name Clotrimazole
    Lab Code
    Clinical Phase III
    Study Title

    A Prospectively Randomized, Blinded, Parallel Group Study of Clotrimazole Troches vs. Mycelex® Troches (10 mg troche five times a day for 14 days) in Patients With Human Immunodeficiency VIrus (HIV) Infection for the Treatment of Oropharyngeal Candidiasis

    Study Document Trial synopsis 1190.1_CO english

Clinical Trial Registry and structured study results. Find here protocol information for all clinical study types.

European Trial Register of EU studies.